Table 2.
CMR findings.
| Variable | All Patients (n = 147) |
Survivors (n = 119) |
Non-Survivors (n = 19) |
p |
|---|---|---|---|---|
| LV ejection fraction (%) | 48 (40, 53) | 48 (40, 53) | 47 (40, 50) | 0.678 |
| LVEDV (mL) | 132 (114, 153) | 131 (113, 151) | 140 (121, 160) | 0.200 |
| LVESV (mL) | 68 (55, 82) | 68 (53, 81) | 72 (60, 82) | 0.403 |
| FT-GLS (%) | −14.2 (−11.3, −18.2) | −14.5 (−11.5, −18.8) | −12.6 (−9.2, −16.4) | 0.097 |
| TT-GLS (%) | −10.4 (−8.6, −12.8) | −10.9 (−8.8, −13.3) | −8.9 (−7.6, −11.3) | 0.032 |
| LAS (%) | −11.2 (−9.1, −14.2) | −12.0 (−9.5, −14.5) | −10.2 (−7.7, −12.8) | 0.014 |
| Myocardial edema * | 101/125 (80.8) | 82/99 (82.8) | 12/18 (66.7) | 0.112 |
| LGE | - | - | - | |
| LV thrombus | 3/147 (2.0) | 2/119 (1.7) | 1/19 (5.3) | 0.320 |
| Pericardial effusion | 48/147 (32.7) | 37/119 (31.1) | 7/19 (36.8) | 0.618 |
| Pleural effusion | 63/147 (42.9) | 49/119 (41.2) | 11/19 (57.9) | 0.172 |
| RV involvement | 41/147 (27.9) | 30/119 (25.2) | 8/19 (42.1) | 0.126 |
Data are presented as n/N (%) or median (IQR). p-values were calculated for the comparison between survivors and non-survivors during long-term follow-up. Nine patients were lost to follow-up. * T2-weighted sequences with sufficient image quality available in 125/147 patients (85%). EDV = end-diastolic volume; ESV = end-systolic volume; FT = feature tracking; GLS = global longitudinal strain; LAS = long-axis strain; LGE = late gadolinium enhancement; LV = left ventricular; RV = right ventricular; TT = tissue tracking.